1. Home
  2. CVE vs ONC Comparison

CVE vs ONC Comparison

Compare CVE & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenovus Energy Inc

CVE

Cenovus Energy Inc

N/A

Current Price

$27.53

Market Cap

48.0B

Sector

Energy

ML Signal

N/A

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$408.98

Market Cap

40.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVE
ONC
Founded
2009
2010
Country
Canada
Switzerland
Employees
N/A
12000
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0B
40.6B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
CVE
ONC
Price
$27.53
$408.98
Analyst Decision
Buy
Strong Buy
Analyst Count
16
27
Target Price
$37.05
★ $437.57
AVG Volume (30 Days)
★ 6.3M
356.4K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 2.24%
N/A
EPS Growth
N/A
★ 140.43
EPS
N/A
★ 0.56
Revenue
N/A
★ $238,387,000.00
Revenue This Year
$29.04
$26.55
Revenue Next Year
N/A
$14.91
P/E Ratio
★ $18.07
$674.61
Revenue Growth
N/A
★ 22179.16
52 Week Low
$15.63
$253.95
52 Week High
$34.16
$388.66

Technical Indicators

Market Signals
Indicator
CVE
ONC
Relative Strength Index (RSI) 29.75 68.35
Support Level $27.51 $335.44
Resistance Level $27.65 N/A
Average True Range (ATR) 1.12 10.85
MACD -0.60 2.30
Stochastic Oscillator 2.20 96.48

Price Performance

Historical Comparison
CVE
ONC

About CVE Cenovus Energy Inc

Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: